The carbohydrate target is under 20 to 50 grams of net carbohydrates per day depending on individual metabolic flexibility
Operations are conducted within the United States to support dependable fulfillment and professional handling for research institutions, laboratories, and qualified facilities
20 However, a retrospective single-institution study showed that although other anti-diabetic medications (such as sodium-glucose cotransporter 2 inhibitors) were associated with a lower risk of sight-threatening DR, GLP-1RAs were not shown to confer any increased DR risk, clinical worsening, or increased intervention in DR
However, results can vary, and it should be used under guidance
Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S (2020) Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and Cardiovascular Diseases
Individuals who may benefit from physician-directed Disodium EDTA IV chelation therapy include: Adults over age 50 with age-related toxin or heavy metal accumulation Individuals with a personal or family history of cardiovascular disease Patients with reduced circulation or vascular health concerns Individuals with diabetes and related circulatory complications Those with known or suspected heavy metal exposure Patients experiencing fatigue, cognitive changes, memory concerns, or neuropathy Individuals with elevated blood pressure or arterial plaque buildup Patients seeking adjunctive support for immune, nervous system, or endocrine function Chelation therapy is personalized and requires medical evaluation and provider oversight to determine appropriateness and treatment planning